Riskpilot← Back to searchSign inGet full accessValiteQ consulting AB
ABActiveOrg 5591125231Hästhagsvägen 22Engineering activities and related technical consultancy · NACE 7112Est. 20172 employees
Revenue 2025
SEK 3,7M
+10% vs 2024
EBITDA margin
39.9%
-19% vs 2024
Equity ratio
87.4%
Financial strength
Net profit 2025
SEK 1,2M
-49% vs 2024
| Revenue | SEK 3,7M | +10% |
| EBITDA | SEK 1,5M | -19% |
| Net profit | SEK 1,2M | -49% |
| Total assets | SEK 5,2M | +14% |
| Equity | SEK 4,6M | +13% |
| Employees | 2 | — |
Legal name
ValiteQ consulting AB
Org number
5591125231
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
17 maj 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom Life Science området (läkemedel, bioteknik och medicinteknik).
Address
Hästhagsvägen 22
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 587 | 4 235 | 3 406 | 3 350 | 3 671 |
| Staff expenses | — | −2 252 | −1 830 | −1 200 | — |
| EBITDA | 1 653 | 1 647 | 1 212 | 1 812 | 1 465 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | 1 653 | 1 647 | 1 212 | 1 812 | 1 465 |
| Net financials | −2 | −3 | −1 | 712 | 2 |
| Profit before tax | 1 651 | 1 645 | 1 212 | 2 524 | 1 467 |
| Tax | −366 | −364 | −275 | −230 | −302 |
| Net profit | 1 285 | 1 281 | 937 | 2 294 | 1 165 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 409 | 3 341 | 3 627 | 4 576 | 5 232 |
| Equity | 1 991 | 2 191 | 2 368 | 4 051 | 4 575 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 961 | 573 | 562 | 525 | 657 |
| Total debt | 961 | 573 | 562 | 525 | 657 |
EBITDA margin
39.9%
This company
15.8%
Market median
+153% vs market
20212025
Equity ratio
87.4%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
25.5%
This company
18.4%
Market median
+39% vs market
20212025
Net profit margin
31.7%
This company
8.1%
Market median
+291% vs market
20212025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
FK Auditor Substitute | Auditor Substitute | 2022 |
UC | Audit | 2022 |
DF | Audit | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ValiteQ consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frida Kristina Nyman | Auditor Substitute | 0 companies |
| Ulrika Christina Eriksson | Audit | 0 companies |
| Daniel F A Bergman Eizyk | Audit | 0 companies |
| Ann-Sofie Heidenfors | Deputy Board Member | 0 companies |
| Inger Katrin Karlsson | Board of Directors | 0 companies |